Other Events ·
Profound Medical Corp. announced new data from the CAPTAIN randomized controlled trial comparing the TULSA Procedure…
PROFProfound Medical Corp.
Profound Medical Corp. announced new data from the CAPTAIN randomized controlled trial comparing the TULSA Procedure with robotic radical prostatectomy. At 1 month post-procedure, the TULSA Procedure demonstrated no median change in penile length, whereas robotic radical prostatectomy showed a median 0.65 cm reduction. Profound Medical Corp. is a medical device company that develops and markets innovative interventional MRI (iMRI) procedures.